First regulate cannabis cultivation. Licence it after
Summarized and contextualized by DistantNews.
TLDR
- Nepal is considering licensing cannabis cultivation for medicinal and industrial purposes, but a Johns Hopkins researcher warns that scientific and legal frameworks must precede licensing.
- The article stresses the need to classify cannabis varieties (e.g., industrial hemp vs. medicinal) and implement mandatory laboratory testing for cannabinoid profiles, contaminants, and residues.
- Without a clear THC threshold and accredited testing facilities, Nepal risks creating a flawed regulatory system that endangers consumers and fails to manage the crop effectively.
As Nepal contemplates the legalization and licensing of cannabis cultivation for medicinal and industrial use, it stands at a critical juncture. Drawing on extensive research and observation of global cannabis programs, a specialized perspective highlights the paramount importance of establishing a robust scientific and legal architecture *before* the first license is issued. Retrofitting regulations after a crisis emerges is a recipe for failure, a mistake that jurisdictions worldwide have already made.
The scientific and legal architecture must be in place before the first license is issued, not retrofitted after the first crisis.
The fundamental error in many premature cannabis regulatory frameworks is the failure to distinguish between different types of cannabis. The plant exists on a spectrum, from industrial hemp with minimal psychoactivity, valuable for its fiber and seed, to potent medicinal varieties with significant pharmacological effects. Nepal must legally define these distinctions, likely using a tetrahydrocannabinol (THC) thresholdโsimilar to the EU's 0.2% or the US/Canada's 0.3%โto differentiate between a legal fiber crop and a controlled substance. Without such a clear boundary, effective regulation and inspection become impossible.
The foundational error in almost every premature cannabis regulatory programme is treating cannabis as a single substance. It is not.
Crucially, mandatory laboratory testing must be the cornerstone of any regulatory system. The accuracy of product labeling in established markets like the US has shown significant deviations, sometimes exceeding 20% for THC content. Nepal, with no existing testing infrastructure, must anticipate even greater challenges. Every batch of cannabis, from cultivation to final product, needs certification from an accredited laboratory. This testing must cover cannabinoid profiles, microbial contamination, mycotoxins, heavy metals, and pesticide residues, especially given cannabis's known tendency to hyperaccumulate heavy metals from soil.
Mandatory laboratory testing is the mechanism through which every other promise a cannabis law makes is either honoured or broken.
The path forward requires a deliberate and informed approach. Nepal must prioritize the development of accredited testing laboratories and establish clear legal definitions for different cannabis types. Rushing into licensing without these foundational elements in place risks not only consumer safety but also the potential for illicit markets to thrive, undermining the intended benefits of medicinal and industrial cannabis programs. A well-regulated system, built on scientific understanding and rigorous testing, is essential for Nepal to harness the potential of cannabis responsibly.
Cannabis is a documented hyperaccumulator of heavy metals from contaminated soil. This is a known failure mode.
Originally published by Kathmandu Post. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.